
Pfizer
About
Breakthroughs That Change Patients' Lives: Pfizer is a leading research-based biopharmaceutical company. We apply science and our global resources to deliver innovative therapies that extend and significantly improve lives. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time.To learn more, visit www.pfizer.com.
Key facts
At-a-glance profile data
- Website
- pfizer.com
- Type
- Company
- Headquarters
- United States
- Portfolio companies
- 1
- Stages
- Strategic
- Cheque size
- $20M to $250M
- Sector focus
- HealthcareDrug DiscoveryClinical DevelopmentBiomarkersTarget Discovery
Recent investments
| Date | Company | Round | Amount |
|---|---|---|---|
| 17 Jul 2024 | CytoReason | Series B | $80M |
| 20 Sept 2022 | CytoReason | Strategic | $20M |
| 10 May 2022 | 1041729 | Undisclosed round | $250M |
Add first review
Frequently asked
What companies has Pfizer invested in?
Pfizer has invested in CytoReason, 1041729.